1) Lymphatic Target Chemotherapy
淋巴靶向化疗
2) 5-FU
5-FU淋巴靶向化疗
1.
Effect of Lymphatic Target Chemotherapy with Carbon Nanoparticles Absorping 5-FU on Expression of Bcl-2, Bax and Caspase-3 in Gastric Cancer Tissues and Metastatic Lymph Nodes;
纳米炭吸附5-FU淋巴靶向化疗影响胃癌组织及转移淋巴结中Bcl-2、Bax及Caspase-3表达的研究
4) lymphatic chemotherapy
淋巴化疗
1.
Effect of preoperative lymphatic chemotherapy on Bcl-2 and Bax expression in axillary metastasis of breast cancer;
术前淋巴化疗对乳腺癌腋窝转移癌细胞Bcl-2和Bax蛋白表达的影响
2.
From the character of rectal cancer metastasis and the results of other solid tumor lymphatic chemotherapy, we think rectal cancer lymphatic chemotherapy maybe also have great significance.
根据结直肠癌的转移特性及其他实体瘤淋巴化疗研究成果认为直肠癌的淋巴化疗可能也具有重要意义。
5) lymphangial chemotherapy
淋巴化疗
1.
Methods 64 patients were divided into two groups,one group was only treated with arteria infusion chemotherapy(simple treatment group)and the other with arteria infusion chemotherapy and lymphangial chemotherapy by injecting chemotherapeutic agents absorbed by active carbon into stomach mucosa (united treatment group).
方法 把 6 4例患者随机分成二组 ,一组行动脉灌注化疗 :术前 1 w经股动脉插管至胃右动脉或胃网膜右动脉灌注化疗药 ;另一组行淋巴化疗加动脉灌注 :术前 1 0 d行内镜胃黏膜下多点注入化疗药使其从淋巴道吸收 ,7d时再行动脉灌注化疗。
6) Targeted chemotherapy
靶向化疗
1.
Targeted chemotherapy and its related treatment for gastric cancinoma could improve the efficacy of drugs in the targeted regions.
收集国内外有关胃癌靶向化疗及与化疗相关治疗的研究进展文献并作一综述。
补充资料：腹膜后淋巴化疗
腹膜后淋巴化疗
腹膜后淋巴结是妇科恶性肿瘤转移的常见部位，直接将化疗药物注入腹膜后经淋巴道治疗腹膜后淋巴结转移称为腹膜后淋巴化疗。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条